Juno Bio
Edit

Juno Bio

https://www.junodx.com/
Last activity: 31.07.2023
Active
Categories: BuildingDiagnosticsHardwareHealthTechHomeInformationOwnTechnology
Affordable and accessible at-home gender test, as early as 7 weeks into the pregnancy. No appointments required, take the test in the comfort of your home.
Website visits
15K /mo.
Mentions
7
Location: United States, California, San Diego
Employees: 11-50
Founded date: 2017

Investors 5

Mentions in press and media 7

DateTitleDescription
31.07.2023Femtech: Juno Diagnostics Shuts Down Commercial OperationsWhat You Should Know: Juno Diagnostics, a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions announced it has ceased commercial operations, effective immediately. The company...
30.01.2023Juno Diagnostics’ Co-Founder and CEO, Dirk van den Boom, Accepted into Forbes Business CouncilAs a co-founder and CEO, this gives me the opportunity to connect with others on their perspectives related to women’s healthcare, diagnostics, genetic testing solutions, and the overall landscape of the medical industry. SAN DIEGO (PRWEB) ...
19.01.2023Juno Diagnostics™ Launches Its Early At-Home Gender Test on Amazon PrimeWith a few drops of maternal blood, we can examine DNA from your pregnancy and determine whether you're expecting a boy or a girl. SAN DIEGO (PRWEB) January 19, 2023 Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health in...
04.05.2022Juno Diagnostics™ to Exhibit at the American College of Obstetricians and Gynecologists Annual Clinical and Scientific MeetingOur team is excited to partner with obstetricians, gynecologists, genetic counselors, and other reproductive care team members who share our vision of providing equitable access to Non-Invasive Prenatal Screening (NIPS). SAN DIEGO (PRWEB) M...
12.05.2021Juno Diagnostics Announces Closing of $25 Million Series A Financing Led by Perceptive Xontogeny Venture FundJoin Transform 2021 this July 12-16. Register for the AI event of the year. – Reproductive health pioneers developing genetic testing solutions to dramatically improve access to prenatal care for all women in all geographies – – Experienced...
12.05.2021Juno Diagnostics Closes $25M Series A FinancingJuno Diagnostics, a San Diego, CA-based company focused on improving access to vital genetic health information and led by industry experts, closed an expanded Series A financing round of $25m. The round was led by the Perceptive Xontogeny ...
12.05.2021Juno Diagnostics Announces Closing of $25 Million Series A Financing Led by Perceptive Xontogeny Venture Fund– Reproductive health pioneers developing genetic testing solutions to dramatically improve access to prenatal care for all women in all geographies – – Experienced leadership team developed and launched the industry’s first noninvasive pre...

Reviews 0

Sign up to leave a review

Sign up Log In